![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Vinita Puri, Emily Streaker, Ponraj Prabakaran, Zhongyu Zhu & Dimiter S. Dimitrov. (2013) Highly efficient selection of epitope specific antibody through competitive yeast display library sorting. mAbs 5:4, pages 533-539.
Read now
Read now
Shabana Kiyani, Emma Quigley, Amy Schlachter & Anna Treadway. (2006) 10th Annual Drug Discovery Technology® Europe And Infotechpharma® Conference. Expert Opinion on Drug Discovery 1:1, pages 91-94.
Read now
Read now
Achim Rothe, Ralf J Hosse & Barbara E Power. (2006) Ribosome display for improved biotherapeutic molecules. Expert Opinion on Biological Therapy 6:2, pages 177-187.
Read now
Read now
Articles from other publishers (21)
Bernhard Valldorf, Steffen C. Hinz, Giulio Russo, Lukas Pekar, Laura Mohr, Janina Klemm, Achim Doerner, Simon Krah, Michael Hust & Stefan Zielonka. (2022) Antibody display technologies: selecting the cream of the crop. Biological Chemistry 403:5-6, pages 455-477.
Crossref
Crossref
Jiachen Lu, Jianing Ding, Zhaoxia Liu & Tingtao Chen. (2022) Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review). International Journal of Oncology 60:2.
Crossref
Crossref
Phuong Ngoc Pham, Maroš Huličiak, Lada Biedermannová, Jiří Černý, Tatsiana Charnavets, Gustavo Fuertes, Štěpán Herynek, Lucie Kolářová, Petr Kolenko, Jiří Pavlíček, Jiří Zahradník, Pavel Mikulecky & Bohdan Schneider. (2021) Protein Binder (ProBi) as a New Class of Structurally Robust Non-Antibody Protein Scaffold for Directed Evolution. Viruses 13:2, pages 190.
Crossref
Crossref
Adinarayana Kunamneni, Christian Ogaugwu, Steven Bradfute & Ravi Durvasula. (2020) Ribosome Display Technology: Applications in Disease Diagnosis and Control. Antibodies 9:3, pages 28.
Crossref
Crossref
Ruowei Li, Guangbo Kang, Min Hu & He Huang. (2018) Ribosome Display: A Potent Display Technology used for Selecting and Evolving Specific Binders with Desired Properties. Molecular Biotechnology 61:1, pages 60-71.
Crossref
Crossref
Kathryn E. Tiller, Ratul Chowdhury, Tong Li, Seth D. Ludwig, Sabyasachi Sen, Costas D. Maranas & Peter M. Tessier. (2017) Facile Affinity Maturation of Antibody Variable Domains Using Natural Diversity Mutagenesis. Frontiers in Immunology 8.
Crossref
Crossref
Regis Sodoyer. 2016. Biosimilars of Monoclonal Antibodies. Biosimilars of Monoclonal Antibodies
1
62
.
X.‐L. Zhao, L.‐F. Tian, S.‐J. Zhang, J.‐M. Li, H. Feng, L.‐M. Wang, S. Wang, J. Wang, T. Wang & W.‐Q. Chen. (2016)
Novel Human Three‐Domain Antibody Fragments Against
sTNF
α
as Well as tm
TNF
α
with High Affinity Generated by the Combination of Ribosome Display and
E. coli
Expression System
. Scandinavian Journal of Immunology 83:4, pages 267-278.
Crossref
Crossref
Florian Tomszak, Susanne Weber, Jonas Zantow, Thomas Schirrmann, Michael Hust & André Frenzel. 2016. Protein Targeting Compounds. Protein Targeting Compounds
23
54
.
Peter Ravn. 2012. Ribosome Display and Related Technologies. Ribosome Display and Related Technologies
213
235
.
Maria A. Groves & Adrian A. Nickson. 2012. Ribosome Display and Related Technologies. Ribosome Display and Related Technologies
163
190
.
Joseph M. Perchiacca, Moumita Bhattacharya & Peter M. Tessier. (2011) Mutational analysis of domain antibodies reveals aggregation hotspots within and near the complementarity determining regions. Proteins: Structure, Function, and Bioinformatics 79:9, pages 2637-2647.
Crossref
Crossref
D. Lipovsek. (2010) Adnectins: engineered target-binding protein therapeutics. Protein Engineering Design and Selection 24:1-2, pages 3-9.
Crossref
Crossref
Robert Mabry, Katherine E. Lewis, Margaret Moore, Patricia A. McKernan, Thomas R. Bukowski, Kristen Bontadelli, Ty Brender, Shannon Okada, Karen Lum, James West, Joseph L. Kuijper, Dan Ardourel, Secil Franke, Luann Lockwood, Tuyen Vu, Amanda Frank, Mark W. Appleby, Anitra Wolf, Brian Reardon, Nels B. Hamacher, Brenda Stevens, Patsy Lewis, Kenneth B. Lewis, Debra G. Gilbertson, Megan Lantry, Susan H. Julien, Craig Ostrander, Chung Chan, Kelly Byrnes-Blake, Jennifer Brody, Scott Presnell, Brent Meengs, Steven D. Levin & Mark Snavely. (2010) Engineering of stable bispecific antibodies targeting IL-17A and IL-23. Protein Engineering, Design and Selection 23:3, pages 115-127.
Crossref
Crossref
Gerald Beste & David Lowe. 2009. Recombinant Antibodies for Immunotherapy. Recombinant Antibodies for Immunotherapy
55
65
.
Markus Fiedler & Arne Skerra. 2007. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
467
499
.
J.K. Osbourn. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
431
447
.
Patrick Dufner, Lutz Jermutus & Ralph R. Minter. (2006) Harnessing phage and ribosome display for antibody optimisation. Trends in Biotechnology 24:11, pages 523-529.
Crossref
Crossref
Achim Rothe, Ralf J. Hosse & And Barbara E. Power. (2006)
In vitro
display technologies reveal novel biopharmaceutics
. The FASEB Journal 20:10, pages 1599-1610.
Crossref
Crossref
Maria Groves, Steven Lane, Julie Douthwaite, David Lowne, D. Gareth Rees, Bryan Edwards & Ronald H. Jackson. (2006) Affinity maturation of phage display antibody populations using ribosome display. Journal of Immunological Methods 313:1-2, pages 129-139.
Crossref
Crossref
Steffen Schlehuber & Arne Skerra. (2005) Anticalins in Drug Development. BioDrugs 19:5, pages 279-288.
Crossref
Crossref